(PubMed) Wang B, Yu M, Zhang R, Chen S, Xi Y, Duan G
Protein intake and resistance training are critical during treatment
Retatrutide is a triple agonist of GIP, GLP-1, and glucagon receptors, not a third-generation GLP-1
[1] Whilst Wegovy primarily targets metabolic pathways, GLP-1 receptors are also present in various brain regions, including some associated with mood regulation, though a direct link to emotional processing remains hypothetical rather than proven
Genetic predispositions in appetite regulation, insulin sensitivity, and metabolic response to certain medications can significantly influence outcomes
Weekly or biweekly glucose checks during the first month, followed by checks at 6 and 12 weeks, represent standard practice